K-V Pharma Emerges From Chapter 11 With $375 Mln Recapitalization - ...

K-V Pharma Emerges From Chapter 11 With $375 Mln Recapitalization
NASDAQ
(RTTNews.com) - K-V Pharmaceutical Co. (KV.A) Monday said that its plan of reorganization has become effective and that it has successfully emerged from chapter 11 with a notably reduced debt and a $375 million recapitalization. Pursuant to the plan, ...